Sonnet Biotherapeutics Holdings, Inc.
SONN
Revenue
18.63k
▼-18.22k▼-49.45%
6 Months ChangeAssets
5.80M
▼-112.61k▼-1.91%
3 Months ChangeLiabilities
3.18M
▲323.56k▲11.33%
3 Months ChangeFree Cash Flow
-1.92M
▼-95.04k▼-5.19%
3 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-17
Form 8-K
ID: 0001493152-24-041363
2024-10-09
Form 8-K
ID: 0001493152-24-040533
2024-09-30
Form 8-K
ID: 0001493152-24-038700
2024-09-18
Form 8-K
ID: 0001493152-24-036945
2024-09-12
Form 8-K
ID: 0001493152-24-036077
2024-09-09
Form 8-K
ID: 0001493152-24-035465
2024-08-30
Form 8-K
ID: 0001493152-24-034482
2024-08-19
Form 8-K
ID: 0001493152-24-032981
2024-08-14
Form 10-Q
ID: 0001493152-24-031909
2024-08-14
Form 8-K
ID: 0001493152-24-031905